scholarly journals Long-Term Results of Reconstruction for Treatment of a Flexible Cavovarus Foot in Charcot-Marie-Tooth Disease

2008 ◽  
Vol 90 (12) ◽  
pp. 2631-2642 ◽  
Author(s):  
Christina M Ward ◽  
Lori A Dolan ◽  
D Lee Bennett ◽  
Jose A Morcuende ◽  
Reginald R Cooper
Keyword(s):  
Long Term Results ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Tooth Disease

Long term results of the revisited Meary closing wedge tarsectomy for the treatment of the fixed cavo-varus foot in adolescent with Charcot-Marie-Tooth disease

2019 ◽  
Vol 25 (6) ◽  
pp. 834-841 ◽  
Author(s):  
Anne-Laure Simon ◽  
Raphaël Seringe ◽  
Alina Badina ◽  
Nejib Khouri ◽  
Christophe Glorion ◽  
...  
Keyword(s):  
Long Term Results ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Closing Wedge ◽  
Tooth Disease

Long-Term Effective Thalamic Deep Brain Stimulation for Neuropathic Tremor in Two Patients with Charcot-Marie-Tooth Disease

2017 ◽  
Vol 95 (2) ◽  
pp. 102-106 ◽  
Author(s):  
Lidia Cabañes-Martínez ◽  
Marta Del Álamo de Pedro ◽  
Gema de Blas Beorlegui ◽  
Ignacio Regidor Bailly-Bailliere
Keyword(s):  
Deep Brain Stimulation ◽  
Brain Stimulation ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Tooth Disease ◽  
Deep Brain

scholarly journals Long-term Analyses of Innervation and Neuromuscular Integrity in the Trembler-J Mouse Model of Charcot-Marie-Tooth Disease

2013 ◽  
Vol 72 (10) ◽  
pp. 942-954 ◽  
Author(s):  
Jessica Renee Nicks ◽  
Sooyeon Lee ◽  
Kathryne Ann Kostamo ◽  
Andrew Benford Harris ◽  
Amanda M. Sookdeo ◽  
...  
Keyword(s):  
Mouse Model ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Tooth Disease

scholarly journals Therapeutic Development in Charcot Marie Tooth Type 1 Disease

2021 ◽  
Vol 22 (13) ◽  
pp. 6755
Author(s):  
Pierre Miniou ◽  
Michel Fontes
Keyword(s):  
Published Data ◽  
Therapeutic Approaches ◽  
Treatment Efficiency ◽  
Charcot Marie Tooth ◽  
Charcot Marie Tooth Disease ◽  
Therapeutic Development ◽  
Tooth Type ◽  
Tooth Disease

Charcot–Marie–Tooth disease (CMT) is the most frequent hereditary peripheral neuropathies. It is subdivided in two main groups, demyelinating (CMT1) and axonal (CMT2). CMT1 forms are the most frequent. The goal of this review is to present published data on 1—cellular and animal models having opened new potential therapeutic approaches. 2—exploration of these tracks, including clinical trials. The first conclusion is the great increase of publications on CMT1 subtypes since 2000. We discussed two points that should be considered in the therapeutic development toward a regulatory-approved therapy to be proposed to patients. The first point concerns long term safety if treatments will be a long-term process. The second point relates to the evaluation of treatment efficiency. Degradation of CMT clinical phenotype is not linear and progressive.

Sign in / Sign up

Export Citation Format

Share Document